Brief: GBL Says Evaluating Strategic Options for Its Portfolio, Including Imerys, As Part of Normal Business
Feb 21 (Reuters) - Groep Brussel Lambert NV GBLB.BR :
* IT IS PART OF GBL'S NORMAL COURSE OF BUSINESS TO EVALUATE
VARIOUS STRATEGIC OPPORTUNITIES FOR ITS PORTFOLIO COMPANIES,
INCLUDING IMERYS
* GBL DOES NOT INTEND TO COMMENT FURTHER ON MARKET RUMOURS
OR
PRESS SPECULATION
Source text: https://shorturl.at/t4Dq1
Further company coverage: GBLB.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Groep Brussel Lambert NV
See all newsRecordati posts nearly 8% rise in core profit, skips interim dividend ahead of delisting
Italy - Factors to watch on November 10
CVC, GBL secure over 90% of Recordati, clear path to delisting
Brief: CVC, GBL secure over 90% of Recordati, paving way for delisting, Reuters calculations show
Brief: GBL Posts NAV Per Share Of €99.21 As Of End September